Detalhe da pesquisa
1.
Population pharmacokinetic analysis of enrofloxacin and its active metabolite ciprofloxacin after intravenous injection to cats with reduced kidney function.
J Vet Intern Med
; 37(6): 2230-2240, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37728198
2.
Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity.
Pharmacogenet Genomics
; 22(10): 733-40, 2012 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-22850190
3.
Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis.
Br J Clin Pharmacol
; 71(4): 566-74, 2011 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-21204907
4.
Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine.
Arch Toxicol
; 84(8): 597-607, 2010 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-20221587
5.
Dapsone-associated methemoglobinemia in a patient with slow NAT2*5B haplotype and impaired cytochrome b5 reductase activity.
J Clin Pharmacol
; 52(2): 272-8, 2012 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-21422237